Catalyst OrthoScience Expands its Single-Tray Portfolio Options

Catalyst OrthoScience Inc. is introducing a single-tray option for the Catalyst Fracture system, a strategic step that positions the company as the first and only to offer a single-tray portfolio for anatomic, reverse, and fracture procedures. 

Slated for official unveiling at the upcoming Shoulder360 Annual Meeting (April 23-25, Miami South Beach), the portfolio expansion represents a significant advancement in shoulder surgery workflow efficiency and gives surgeons partnering with Catalyst access to a streamlined, single-tray for all major shoulder arthroplasty cases—stemless anatomic, reverse, and reverse for fracture, according to the company.  Each is designed with predictable layouts, a compact footprint, and fewer instruments to support faster decision-making and lower processing demands, and up to 46% fewer operative steps than competitive systems,¹ all without compromising surgical options. 

This launch coincides with the 10th anniversary of the first Catalyst CSR implant. Since that first clinical case, Catalyst has delivered numerous innovations focused on shoulder anatomy and solving clinical and operational challenges that deliver measurable value to surgeons, care teams , and facilities. This first decade of advancements for shoulder arthroplasty has been guided by surgeon insight and reinforced by a growing body of published, peer-reviewed clinical evidence, company bigwigs said. 

“We started Catalyst to make shoulder replacement surgery more predictable for surgeons with better outcomes for patients. Ten years and many new products later, the ambition to move our field forward hasn’t changed,” stated Catalyst OrthoScience Founder Dr. Steven Goldberg, an orthopedic surgeon at Physicians Regional Healthcare System in Naples, Fla.

At a time when hospitals and ambulatory surgery centers (ASCs) are under growing pressure to improve efficiency, accelerate case turnover, and control costs, Catalyst is delivering surgeon-first solutions that strive to elevate care for patients and streamline operations for facilities. Anchored by its single-tray portfolio, Catalyst empowers surgical teams to reduce complexity and instrument burden without sacrificing the flexibility and performance on which they depend. 

“O.R. teams face relentless pressure to do more with less, and the traditional way of doing things won’t fix that. Our response is innovation that produces meaningful gains, not incremental tweaks,” Catalyst OrthoScience President/CEO Carl O’Connell said. “For 10 years, we’ve challenged outdated approaches and partnered with surgeons to eliminate unnecessary complexity. By reducing tray count, simplifying setup, and creating predictable layouts, the expansion of our single-tray portfolio shows exactly how far that mindset can take us—and we’re just getting started.” 

Founded in 2014 and based in Naples, Fla., Catalyst OrthoScience is attempting to redefine shoulder replacement surgery. With a focus on less invasive techniques, fewer complications, and a more natural-feeling shoulder, the company’s solutions are engineered for precision and efficiency—preserving bone and soft tissue while delivering consistent, reproducible results. With a growing portfolio of issued and pending patents, Catalyst technology is available across the United States.

References
¹ Data on file.